NCT06149247 2025-08-20
HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL
Soligenix
Phase 2 Completed
Soligenix
Centre for Human Drug Research, Netherlands
Rochester Skin Lymphoma Medical Group, PLLC
Helsinn Therapeutics (U.S.), Inc